Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report.

MLA

Toda, Soji, et al. “Hyperthyroidism Due to Thyrotropin Receptor Antibody Stimulation of Metastatic Thyroid Carcinoma during Lenvatinib Treatment: A Case Report.” Annals of Palliative Medicine, vol. 11, no. 11, Nov. 2022, pp. 3571–77. EBSCOhost, https://doi.org/10.21037/apm-22-276.

APA

Toda, S., Kadoya, M., Matsui, A., Murayama, D., & Iwasaki, H. (2022). Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report. Annals of Palliative Medicine, 11(11), 3571–3577. https://doi.org/10.21037/apm-22-276

Chicago

Toda, Soji, Mei Kadoya, Ai Matsui, Daisuke Murayama, and Hiroyuki Iwasaki. 2022. “Hyperthyroidism Due to Thyrotropin Receptor Antibody Stimulation of Metastatic Thyroid Carcinoma during Lenvatinib Treatment: A Case Report.” Annals of Palliative Medicine 11 (11): 3571–77. doi:10.21037/apm-22-276.